IMNR - Immune Response Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMNR - Immune Response

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Chris Wilkinson who wrote (147)	10/28/1997 8:16:00 PM
From: Mark B. Martell, CCM	Read Replies (1) of 1510

That's true Chris. I just ASS U ME'd that you had already checked there first before posting to the thread. I just visited the site myself for the first time in ages and they've added quite a bit. Today's late day rally was kind of nice, closing at the ask. This is a long term play for me though and you'll have to pry the certificates from my fingers before I'll sell. They've got a decent pipeline which is early on in the drug testing stages, but with great potential. I believe that if Remune turns out to be a $200-$300MM per year drug, this stock will move to the $30-50 range. If Remune turns out to provide only a marginal benefit, we'll have to wait until the other compounds get through to the later stages (Phases 3-5) before we can see any stock success. Irregardless, a good buy and hold play. Hold for eighteen months and sell. Mark

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next